Photodynamic Therapy For Recurred Subfoveal Choroidal Neovascularization After Argon-Laser Photocoagulation. |
Min Joung Lee, Su Jeong Song, Hum Chung, Hyeong Gon Yu |
1Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea. hgonyu@snu.ac.kr 2Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea. |
아르곤레이저 치료후 재발한 중심와아래 맥락막신생혈관에 대한 광역학치료 |
이민정,송수정,정흠,유형곤 |
Department of Ophthalmology, Seoul National University College of Medicine, Seoul, Korea Seoul Artificial Eye Center, Clinical Research Institute, Seoul National University Hospital, Seoul, Korea |
Correspondence:
Min-Joung Lee, M.D. |
|
Abstract |
PURPOSE To evaluate the effects of photodynamic therapy for subfoveal recurrences of juxtafoveal or extrafoveal choroidal neovascularization (CNV), previously treated with argon-laser photocoagulation. METHODS: Seven eyes, previously treated with argon-laser photocoagulation for juxtafoveal or extrafoveal choroidal neovascularization, received photodynamic therapy for subfoveal recurrence. Changes in visual acuity and fluorescein angiographic findings were analyzed. RESULTS: The average time of appearance of recurrent CNV after laser photocoagulation was 43.14+/-29.62 months (range, 2-77 months). After photodynamic therapy, fluorescein leakage and neovascular lesion size decreased in all patients on fluorescein angiography. Visual acuity was stabilized or improved in 5 of 7 eyes. CONCLUSIONS: Photodynamic therapy was effective in patients with subfoveal recurrences of juxtafoveal or extrafoveal choroidal neovascularization previously treated with argon-laser photocoagulation. |
Key Words:
Argon-laser photocoagulation;Choroidal neovascularization;Photodynamic therapy;Recurrence;Subfoveal |
|